logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 7 of 7 Items
Showing 1 - 7 of 7 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis

Hamada Y, Gupta RS, Quartagno M, Izzard A, Acuna-Villaorduna C,  et al.
2023-02-01 • eClinicalMedicine
2023-02-01 • eClinicalMedicine
BACKGROUND
Evidence on the comparative performance of purified protein derivative tuberculin skin tests (TST) and interferon-gamma release assays (IGRA) for predicting incident activ...
Journal Article
|
Research

Diagnostic accuracy of tuberculin skin test self-reading by HIV patients in a low-resource setting

Cox V, De Azevedo V, Stinson K, Wilkinson LS, Rangaka MX,  et al.
2015-11-01 • International Journal of Tuberculosis and Lung Disease
2015-11-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND
The World Health Organization recommends tuberculin skin tests (TSTs) where feasible to identify individuals most likely to benefit from isoniazid preventive therapy (IPT)...
Journal Article
|
Research

Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection

Rangaka MX, Wilkinson KA, Seldon R, van Cutsem G, Meintjes GA,  et al.
2007-12-07 • American Journal of Respiratory and Critical Care Medicine
2007-12-07 • American Journal of Respiratory and Critical Care Medicine
RATIONALE: Two forms of the IFN-gamma release assay (IFNGRA) to detect tuberculosis infection are available, but neither has been evaluated in comparable HIV-infected and uninfected pers...
Journal Article
|
Research

Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial

Rangaka MX, Wilkinson RJ, Boulle AM, Glynn JR, Fielding K,  et al.
2014-05-14 • Lancet
2014-05-14 • Lancet
Antiretroviral therapy reduces the risk of tuberculosis, but tuberculosis is more common in people with HIV than in people without HIV. We aimed to assess the effect of isoniazid prevent...
Journal Article
|
Research

Effect of Antiretroviral Therapy on the Diagnostic Accuracy of Symptom Screening for Intensified Tuberculosis Case Finding in a South African HIV clinic

Rangaka MX, Wilkinson RJ, Glynn JR, Boulle AM, van Cutsem G,  et al.
2012-09-05 • Clinical Infectious Diseases
2012-09-05 • Clinical Infectious Diseases
Current symptom screening algorithms for intensified tuberculosis case finding or prior to isoniazid preventive therapy (IPT) in patients infected with human immunodeficiency virus (HIV)...
Journal Article
|
Research

Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: a systematic review and individual participant data meta-analysis

Dhana A, Hamada Y, Kengne AP, Kerkhoff AD, Broger T,  et al.
2022-05-16 • Journal of Infection
2022-05-16 • Journal of Infection
BACKGROUND
WHO recommends urine lateral-flow lipoarabinomannan (LF-LAM) testing with AlereLAM in HIV-positive inpatients only if screening criteria are met. We assessed the performan...
Journal Article
|
Research

Tuberculosis screening among HIV-positive inpatients: a systematic review and individual participant data meta-analysis

Dhana A, Hamada Y, Kengne AP, Kerkhoff AD, Rangaka MX,  et al.
2022-04-01 • Lancet HIV
2022-04-01 • Lancet HIV
BACKGROUND
Since 2011, WHO has recommended that HIV-positive inpatients be routinely screened for tuberculosis with the WHO four-symptom screen (W4SS) and, if screened positive, rece...